AVEXA LIMITED (AVX)

Research and development of anti-infective treatments for HIV, Hepatitis C and antibiotic resistant bacteria.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
AVX	0.017	0%	0.016	0.017	0.000	0.000	0.000	0

AVEXA LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	AVX
Securities	ASX Code, Security Description ------------------------------ AVX, Ordinary Fully Paid
Official Listing Date	23 September, 2004
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.avexa.com.au
Registered Office Address	576 Swan Street, RICHMOND, VIC, AUSTRALIA, 3121
Head Office Telephone	(03) 9208 4300
Head Office Fax	(03) 9208 4146
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Iain Kirkwood (Chairman) Dr Jonathan Coates (CEO) Mr Bruce Hewett (Non Exec. Director) Mr Allan Tan (Non Exec. Director)

Company Secretary	Mr Lee Mitchell
Principal Activities	Research and development of anti-infective treatments for HIV, Hepatitis C and antibiotic resistant bacteria.

AVEXA LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
06/05/2013		Change of Director's Interest Notice	2	PDF
29/04/2013		Appendix 4C - quarterly	5	PDF
22/04/2013		Avexa makes progress on North Pratt Coal Mine	2	PDF
08/04/2013		CEO on H1 Update and Company Outlook	4	PDF
04/03/2013		Change of Director's Interest Notice	2	PDF
28/02/2013		Change of Director's Interest Notice	2	PDF
28/02/2013		Change of Director's Interest Notice	2	PDF
21/02/2013		Company Update	4	PDF
21/02/2013		Half Yearly Report and Accounts	21	PDF
11/02/2013		Ceasing to be a substantial holder	2	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
20 May 2013	0.017	6.25%	0.017	0.015	645,335
17 May 2013	0.016	-5.88%	0.017	0.016	464,951
16 May 2013	0.017	0%	0.017	0.017	250,000
14 May 2013	0.017	0%	0.017	0.016	147,893
13 May 2013	0.017	-5.56%	0.018	0.017	689,213

* Volume of shares shown represents only those shares traded on ASX.

AVEXA LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security AVX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security AVX

Warrants & Structured Products

No warrants & Structured Products are available over the security AVX

ASX CFDs

No Contracts For Differences are available over the security AVX

MyASX: Login | Sign up